mTOR signaling: PLD takes center stage

The mammalian target of rapamycin (mTOR) assembles a signaling network that transduces nutrient signals and various other stimuli to regulate a wide range of cellular functions. Of the two distinct mTOR complexes, mTORC1 is under the control of the TSC-Rheb pathway, which serves as an integrator of multiple upstream signals. A lipid signaling cascade involving phospholipase D (PLD) and phosphatidic acid (PA) has also been known to mediate mitogenic signals upstream of mTORC1. A new study now reveals a direct connection between these two regulatory pathways and demonstrates that PLD1 is an effector of Rheb in the activation of mTORC1. A novel role of PLD as a nutrient sensor has also been suggested. In this extra-view, we discuss the emerging importance of PA and PLD in the mTORC1 signaling network and the biological processes it governs. We also consider the implications from several recent findings and propose mechanistic models of PLD-mTOR signaling to be tested in the near future.

[1]  G. Du,et al.  Ca2+‐ and phospholipase D‐dependent and ‐independent pathways activate mTOR signaling , 2003, FEBS letters.

[2]  In-Hyun Park,et al.  PLD1 Regulates mTOR Signaling and Mediates Cdc42 Activation of S6K1 , 2003, Current Biology.

[3]  A. Gingras,et al.  Regulation of translation initiation by FRAP/mTOR. , 2001, Genes & development.

[4]  C. Proud,et al.  PRAS40 Is a Target for Mammalian Target of Rapamycin Complex 1 and Is Required for Signaling Downstream of This Complex* , 2007, Journal of Biological Chemistry.

[5]  A. Nakashima,et al.  The Proline-rich Akt Substrate of 40 kDa (PRAS40) Is a Physiological Substrate of Mammalian Target of Rapamycin Complex 1* , 2007, Journal of Biological Chemistry.

[6]  David A Foster,et al.  Alternative phospholipase D/mTOR survival signal in human breast cancer cells , 2005, Oncogene.

[7]  David M. Sabatini,et al.  The Rag GTPases Bind Raptor and Mediate Amino Acid Signaling to mTORC1 , 2008, Science.

[8]  L. Cantley,et al.  Phosphoinositide kinases. , 1998, Annual review of biochemistry.

[9]  Takehiko Sasaki,et al.  Essential Role for Phospholipase D2 Activation Downstream of ERK MAP Kinase in Nerve Growth Factor-stimulated Neurite Outgrowth from PC12 Cells* , 2004, Journal of Biological Chemistry.

[10]  H. Janssens,et al.  BMC Developmental Biology BioMed Central , 2006 .

[11]  X. Bai,et al.  Rheb Activates mTOR by Antagonizing Its Endogenous Inhibitor, FKBP38 , 2007, Science.

[12]  M. Lemmon,et al.  Phosphoinositide Recognition Domains , 2003, Traffic.

[13]  James T. Murray,et al.  hVps34 Is a Nutrient-regulated Lipid Kinase Required for Activation of p70 S6 Kinase* , 2005, Journal of Biological Chemistry.

[14]  Xinsheng Gao,et al.  Tuberous sclerosis complex: from Drosophila to human disease. , 2004, Trends in cell biology.

[15]  J. Bos,et al.  Regulation of the small GTPase Rheb by amino acids , 2006, Oncogene.

[16]  Ping Huang,et al.  Insulin-stimulated plasma membrane fusion of Glut4 glucose transporter-containing vesicles is regulated by phospholipase D1. , 2005, Molecular biology of the cell.

[17]  S. Chien,et al.  The role of phospholipase D and phosphatidic acid in the mechanical activation of mTOR signaling in skeletal muscle. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[18]  W. Stark,et al.  Regulation of phototransduction responsiveness and retinal degeneration by a phospholipase D–generated signaling lipid , 2005, The Journal of cell biology.

[19]  A. Gingras,et al.  eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. , 1999, Annual review of biochemistry.

[20]  G. Laurent,et al.  Syk-dependent mTOR activation in follicular lymphoma cells. , 2006, Blood.

[21]  J. Blenis,et al.  Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression , 2004, Oncogene.

[22]  R. Roth,et al.  PRAS40 Regulates mTORC1 Kinase Activity by Functioning as a Direct Inhibitor of Substrate Binding* , 2007, Journal of Biological Chemistry.

[23]  J. Blenis,et al.  The 70 kDa S6 Kinase Complexes with and Is Activated by the Rho Family G Proteins Cdc42 and Rac1 , 1996, Cell.

[24]  J. Exton Regulation of phospholipase D , 2002, Biochimica et biophysica acta.

[25]  N. Sonenberg,et al.  Upstream and downstream of mTOR. , 2004, Genes & development.

[26]  Y. Akao,et al.  Involvement of phospholipase D1 in collagen type I production of human dermal fibroblasts. , 2006, Biochemical and biophysical research communications.

[27]  K. Meier,et al.  Expression of phospholipase D isoforms in mammalian cells. , 1999, Biochimica et biophysica acta.

[28]  G. Hortobagyi,et al.  IKKβ Suppression of TSC1 Links Inflammation and Tumor Angiogenesis via the mTOR Pathway , 2007, Cell.

[29]  M. Hall,et al.  TOR Signaling in Growth and Metabolism , 2006, Cell.

[30]  P. Worley,et al.  Rheb is in a high activation state and inhibits B-Raf kinase in mammalian cells , 2002, Oncogene.

[31]  F. Natt,et al.  Amino acids activate mTOR complex 1 via Ca2+/CaM signaling to hVps34. , 2008, Cell metabolism.

[32]  M. Shi,et al.  Phospholipase D provides a survival signal in human cancer cells with activated H-Ras or K-Ras. , 2007, Cancer letters.

[33]  G. Prestwich,et al.  Activation of mTOR signaling by novel fluoromethylene phosphonate analogues of phosphatidic acid. , 2004, Bioorganic & medicinal chemistry letters.

[34]  J. Avruch,et al.  Rheb Binding to Mammalian Target of Rapamycin (mTOR) Is Regulated by Amino Acid Sufficiency* , 2005, Journal of Biological Chemistry.

[35]  S. Sethu,et al.  Phospholipase D1 plays a key role in TNF-alpha signaling. , 2008, Journal of immunology.

[36]  K. Inoki,et al.  TSC2: filling the GAP in the mTOR signaling pathway. , 2004, Trends in biochemical sciences.

[37]  Ming You,et al.  TSC2 Integrates Wnt and Energy Signals via a Coordinated Phosphorylation by AMPK and GSK3 to Regulate Cell Growth , 2006, Cell.

[38]  M. Frohman,et al.  Phospholipase D structure and regulation. , 1999, Chemistry and physics of lipids.

[39]  S. Nicosia,et al.  Phosphatidylinositol 3-Kinase/Akt Pathway Regulates Tuberous Sclerosis Tumor Suppressor Complex by Phosphorylation of Tuberin* , 2002, The Journal of Biological Chemistry.

[40]  D. A. Foster,et al.  Regulation of mTOR by phosphatidic acid? , 2007, Cancer Research.

[41]  K. Inoki,et al.  TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling , 2002, Nature Cell Biology.

[42]  J. Blenis,et al.  TOS Motif-Mediated Raptor Binding Regulates 4E-BP1 Multisite Phosphorylation and Function , 2003, Current Biology.

[43]  D. A. Foster,et al.  Phospholipase D confers rapamycin resistance in human breast cancer cells , 2003, Oncogene.

[44]  Y. Kam,et al.  Role of phospholipase D1 in the regulation of mTOR activity by lysophosphatidic acid , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  David M Sabatini,et al.  Defining the role of mTOR in cancer. , 2007, Cancer cell.

[46]  S. Rudge,et al.  Regulation and function of PLDs in yeast. , 1999, Biochimica et biophysica acta.

[47]  T. P. Neufeld,et al.  Regulation of TORC1 by Rag GTPases in nutrient response , 2008, Nature Cell Biology.

[48]  L. Cantley,et al.  Rheb fills a GAP between TSC and TOR. , 2003, Trends in biochemical sciences.

[49]  T. P. Neufeld,et al.  The class III PI(3)K Vps34 promotes autophagy and endocytosis but not TOR signaling in Drosophila , 2008, The Journal of cell biology.

[50]  K. Jakobs,et al.  Phospholipase D Stimulation by Receptor Tyrosine Kinases Mediated by Protein Kinase C and a Ras/Ral Signaling Cascade* , 1999, The Journal of Biological Chemistry.

[51]  J. Zempleni,et al.  Amino acid-sensing mTOR signaling. , 2005 .

[52]  Y. Kam,et al.  Phospholipase D Activity Is Required for Actin Stress Fiber Formation in Fibroblasts , 2001, Molecular and Cellular Biology.

[53]  M. Hall,et al.  The expanding TOR signaling network. , 2005, Current opinion in cell biology.

[54]  V. Holla,et al.  Requirement of phospholipase D1 activity in H-RasV12-induced transformation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[55]  I. Mérida,et al.  Modulation of the Mammalian Target of Rapamycin Pathway by Diacylglycerol Kinase-produced Phosphatidic Acid* , 2005, Journal of Biological Chemistry.

[56]  D. Kwiatkowski,et al.  Molecular genetic advances in tuberous sclerosis , 2000, Human Genetics.

[57]  D. Alessi,et al.  TSC1–TSC2: a complex tale of PKB-mediated S6K regulation , 2002, Nature Cell Biology.

[58]  Scott M. Hammond,et al.  Phospholipase D2, a distinct phospholipase D isoform with novel regulatory properties that provokes cytoskeletal reorganization , 1997, Current Biology.

[59]  M. Carr,et al.  Structural characterization of the interaction of mTOR with phosphatidic acid and a novel class of inhibitor: compelling evidence for a central role of the FRB domain in small molecule-mediated regulation of mTOR , 2008, Oncogene.

[60]  Paul Tempst,et al.  Phosphorylation and Functional Inactivation of TSC2 by Erk Implications for Tuberous Sclerosisand Cancer Pathogenesis , 2005, Cell.

[61]  Mee-Sup Yoon,et al.  PLD regulates myoblast differentiation through the mTOR-IGF2 pathway , 2008, Journal of Cell Science.

[62]  J. Avruch,et al.  The Mammalian Target of Rapamycin (mTOR) Partner, Raptor, Binds the mTOR Substrates p70 S6 Kinase and 4E-BP1 through Their TOR Signaling (TOS) Motif* , 2003, The Journal of Biological Chemistry.

[63]  Y. Akao,et al.  Negative regulation of melanogenesis by phospholipase D1 through mTOR/p70 S6 kinase 1 signaling in mouse B16 melanoma cells , 2005, Journal of cellular physiology.

[64]  Jussi Taipale,et al.  Identification of pathways regulating cell size and cell-cycle progression by RNAi , 2006, Nature.

[65]  S. Jang,et al.  PLD2 forms a functional complex with mTOR/raptor to transduce mitogenic signals. , 2006, Cellular signalling.

[66]  D. Bar-Sagi,et al.  Honokiol Suppresses Survival Signals Mediated by Ras-Dependent Phospholipase D Activity in Human Cancer Cells , 2008, Clinical Cancer Research.

[67]  Ping Huang,et al.  Phospholipase D2 localizes to the plasma membrane and regulates angiotensin II receptor endocytosis. , 2003, Molecular biology of the cell.

[68]  J. Lawrence,et al.  Two Motifs in the Translational Repressor PHAS-I Required for Efficient Phosphorylation by Mammalian Target of Rapamycin and for Recognition by Raptor* , 2003, Journal of Biological Chemistry.

[69]  L. Mcphail,et al.  Phospholipase D2‐derived phosphatidic acid binds to and activates ribosomal p70 S6 kinase independently of mTOR , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[70]  Steven P Gygi,et al.  Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[71]  P. Pandolfi,et al.  Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer. , 2007, Cancer research.

[72]  A. Ball,et al.  Inhibition of lysophosphatidic acid acyltransferase beta disrupts proliferative and survival signals in normal cells and induces apoptosis of tumor cells. , 2003, Molecular cancer therapeutics.

[73]  G. Fiucci,et al.  Phospholipase D: molecular and cell biology of a novel gene family. , 2000, The Biochemical journal.

[74]  S. Carr,et al.  PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. , 2007, Molecular cell.

[75]  Z. Freyberg,et al.  Intracellular localization of phospholipase D1 in mammalian cells. , 2001, Molecular biology of the cell.

[76]  David J. Kwiatkowski,et al.  Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[77]  Jie Chen,et al.  A novel pathway regulating the mammalian target of rapamycin (mTOR) signaling. , 2002, Biochemical pharmacology.

[78]  Tian Xu,et al.  Akt regulates growth by directly phosphorylating Tsc2 , 2002, Nature Cell Biology.

[79]  H. A. Brown,et al.  Phospholipase D1 is an effector of Rheb in the mTOR pathway , 2008, Proceedings of the National Academy of Sciences.

[80]  J. Hwang,et al.  Activation of phospholipase D by 8‐Br‐cAMP occurs through novel pathway involving Src, Ras, and ERK in human endometrial stromal cells , 2005, FEBS letters.

[81]  Jie Chen,et al.  Phosphatidic Acid-Mediated Mitogenic Activation of mTOR Signaling , 2001, Science.

[82]  J. Avruch,et al.  The Rheb Switch 2 Segment Is Critical for Signaling to Target of Rapamycin Complex 1* , 2007, Journal of Biological Chemistry.

[83]  F. Natt,et al.  Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[84]  Steven J. Marygold,et al.  Growth Signaling: TSC Takes Its Place , 2002, Current Biology.

[85]  Timothy J. Griffin,et al.  Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40 , 2007, Nature Cell Biology.

[86]  Joseph Avruch,et al.  Rheb Binds and Regulates the mTOR Kinase , 2005, Current Biology.

[87]  M. Shi,et al.  Phospholipase D Couples Survival and Migration Signals in Stress Response of Human Cancer Cells* , 2006, Journal of Biological Chemistry.

[88]  C. Proud,et al.  The Tuberous Sclerosis Protein TSC2 Is Not Required for the Regulation of the Mammalian Target of Rapamycin by Amino Acids and Certain Cellular Stresses* , 2005, Journal of Biological Chemistry.

[89]  G. Du,et al.  Insulin-induced phospholipase D1 and phospholipase D2 activity in human embryonic kidney-293 cells mediated by the phospholipase C gamma and protein kinase C alpha signalling cascade. , 2000, The Biochemical journal.

[90]  J. B. Park,et al.  Activation of astroglial phospholipase D activity by phorbol ester involves ARF and Rho proteins. , 2000, Biochimica et biophysica acta.

[91]  D. A. Foster,et al.  Phospholipase D in cell proliferation and cancer. , 2003, Molecular cancer research : MCR.

[92]  D. Sabatini,et al.  Growing roles for the mTOR pathway. , 2005, Current opinion in cell biology.

[93]  G. Laurie,et al.  Restricted epithelial proliferation by lacritin via PKCα-dependent NFAT and mTOR pathways , 2006, The Journal of cell biology.

[94]  M. Frohman,et al.  Mammalian phospholipase D structure and regulation. , 1999, Biochimica et biophysica acta.